BackOncology Institute(The) Overview
Oncology Institute Inc (The)

Oncology Institute(The) Target Price

Analysts' average 12-month price target for Oncology Institute(The) is $8.5.

Get informed when a big investor buys or sells

+ Follow

Share Price

$5.13

Average Target Price

$8.5065.7% upside

4 analysts in the last 4 months

High: $10 | Low: $7

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-07-09BTIG$975.4% upsideOpen
2026-07-06Lake Street$1094.9% upsideOpen
2026-06-17Needham$736.5% upsideOpen
2026-06-08BTIGDavid Larsen$855.9% upsideOpen
2025-11-25NeedhamMatthew Shea$52.5% downsideOpen
2022-11-11Guggenheim$617% upsideOpen
2022-08-15Jefferies$1094.9% upsideOpen

Oncology Institute(The) (TOI) FAQ

As of the most recent data, TOI shows a target price of $8.5. Scroll down for historical charts and peer comparison views.

If Oncology Institute(The) moved to the average analyst target of $8.5, shares would be roughly 65.7% higher than $5.13. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Oncology Institute(The)'s earnings trajectory.

Besides this target price page, Stockcircle has Oncology Institute(The)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $8.5) with ownership activity and broader fundamentals.